MirZyme Therapeutics granted a new US patent

The MirZyme Therapeutics team are delighted to announce that we have been granted a new US patent to predict and prevent pregnancy complications.

This achievement underscores our dedication to innovation and stands as a testament to the invaluable contributions of our team. Guided by the 5Ps of life—Profession, Addition Passion, Purpose, Persistence, and Persuasion—they are instrumental in our mission to make preeclampsia history.

We are grateful for the help and support as we continue this important work together.